Home ultrasound in telemedicine care for gestational diabetes (GDM)
Official title: Effect of Home Ultrasound in Routine High-Risk Care of Patients With Gestational Diabetes Mellitus
Run by Wolfson Medical Center · NCT07158970 · Data updated 2026-11-12
This study tests whether using a home ultrasound device at home, guided by a physician, improves satisfaction and outcomes for pregnant people with GDM compared to standard care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 51 Years |
| Sex | Women only |
| Enrollment | 90 (estimated) |
| Sponsor | Wolfson Medical Center Government |
| Locations | 1 site (H̱olon, Central District) |
| Status | Recruiting |
| Started | March 1, 2026 |
| Main results expected | August 31, 2027 |
| Study ends | November 1, 2027 |
| Registry record updated | July 2, 2026 |
| Trial ID | NCT07158970 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Hebrew-speaking women with singleton pregnancies and diagnosed GDM who have compatible cellphones and can participate in telemedicine.
✕Probably not a fit
Patients without access to compatible devices or those with exclusion criteria (e.g., pregestational diabetes, fetal anomalies, multifetal pregnancy, late GDM diagnosis) may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center randomized trial compares standard high-risk care for gestational diabetes with a care model that adds physician-guided home ultrasound during telemedicine visits. Participants will alternate in-person and telemedicine visits, using the Pulsenmore device under real-time supervision to assess fetal status. Primary outcome is patient satisfaction at term measured by the DTSQ, with secondary outcomes including glycemic control, maternal and neonatal outcomes, healthcare utilization, visit duration, and costs. The study will enroll 90 women with singleton pregnancies and GDM at Edith Wolfson Medical Center in Israel over one year.
Why it matters
Potential benefit: If successful, the approach could improve patient satisfaction and potentially optimize monitoring while reducing in-clinic visits.
How similar studies have gone: Prior telemedicine approaches have improved access and satisfaction, but this study novelly adds home ultrasound guidance to remote care.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Singleton pregnancy * GDM diagnosed by OGTT or glucose monitoring * Hebrew speaking * Compatible cellphone Exclusion Criteria: * Pregestational diabetes * Fetal anomalies/genetic abnormalities * Multifetal pregnancy * Late GDM diagnosis (after 34 weeks)
Where it's running
-
Edith Wolfson Medical Center
H̱olon, Central District, Israel Recruiting
Study contacts
- Principal investigator: LIat Mor — Edith Wolfson Medical center
- Study coordinator: Liat Mor
- Email: liatmor1@gmail.com
- Phone: +972546738294
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Islet function in gestational diabetes: see if pancreas changes during and after pregnancy
This study tests whether the human pancreas changes its function during and after pregnancy in people with gestational diabetes or not, using Exendin 9-39 in a small Phase 1 trial.
-
Prenatal Exercise to See How Cardio or Strength Training Affects Blood Sugar
This study tests whether different types and amounts of exercise during pregnancy can improve blood sugar control in women with gestational diabetes.
-
Managing cardiometabolic risk in women with gestational diabetes using continuous glucose monitoring and mobile health
This trial will test whether continuous glucose monitoring plus a mobile health lifestyle program helps pregnant women with gestational diabetes control blood sugar and lower cardiometabolic risk for them and their babies.
-
Comparing Metformin and Insulin for Gestational Diabetes Treatment
This study is testing whether metformin is as effective as insulin for treating gestational diabetes in pregnant people and looks at how safe both treatments are for mothers and their babies.
-
Continuous glucose monitoring for pregnant women with gestational diabetes to improve mother and baby outcomes
This project will test whether using continuous glucose monitoring helps pregnant women with gestational diabetes and their babies have better health outcomes than usual monitoring.
-
Investigating how meal timing affects blood sugar during pregnancy
This study is testing how the timing of meals affects blood sugar levels in pregnant women at risk for gestational diabetes to see if it can help manage their health better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.